Timeline Amgen

^ amgen—a biotechnology success story | drug development mass market . 
^ drugs@fda: fda approved drug products . 
^ drugs@fda: fda approved drug products . 
^ lyman gh, kuderer nm, djulbegovic b (april 2002). prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: meta-analysis . am. j. med. 112 (5): 406–11. doi:10.1016/s0002-9343(02)01036-7. pmid 11904116. 
^ chen yf, jobanputra p, barton p, et al. (november 2006). systematic review of effectiveness of adalimumab, etanercept , infliximab treatment of rheumatoid arthritis in adults , economic evaluation of cost-effectiveness . health technol assess. 10 (42): iii–iv, xi–xiii, 1–229. doi:10.3310/hta10420. pmid 17049139. 
^ morgan cl, emery p, porter d, et al. (january 2014). treatment of rheumatoid arthritis etanercept reference disease-modifying anti-rheumatic drugs: long-term safety , survival using prospective, observational data . rheumatology (oxford). 53 (1): 186–94. doi:10.1093/rheumatology/ket333. pmid 24140761. 
^ drugs@fda: fda approved drug products . 
^ www.accessdata.fda.gov (pdf). 
^ fda approves xgeva prevent cancer-related bone injury . 
^ terhune, chad (18 december 2012). amgen pleads guilty improper marketing of anemia drug aranesp . los angeles times. retrieved 2 february 2013. 
^ husten, larry. amgen pleads guilty misbranding anemia drug aranesp . forbes. retrieved 2 february 2013. 
^ article > amgen s aranesp fails in heart trial, singapore plant planned . 
^ amgen inc. pleads guilty federal charge in brooklyn , pays $762 million resolve criminal liability , civil fraud allegations (press release). department of justice – office of public affairs. december 19, 2012. retrieved 3 october 2013. 
^ lipton, eric (19 january 2013). fiscal footnote: big senate gift drug maker . new york times. retrieved 2 february 2013. 
^ jon entine: new york times mum after congressional budget office rebukes bungled amgen/medicare investigation . huffington post. 26 february 2013. 
^ cbo analysis shows keeping oral drugs out of esrd bundle save money | nephrology news & issues . archived original on 2013-06-05. 
^ $1.55b, amgen acquires dezima pharma . gen. 
^ amgen bets $1.7b on xencor s antibody technology . fiercebiotech. 
^ amgen, xencor partner on cancer immunotherapy, inflammation drugs . gen. 
^ amgen buys rights myeloma bite immunotherapy boehringer ingelheim - gen news highlights - gen .